Clara Shen

Clara Shen is an accomplished executive with extensive experience in various sectors, currently serving at Dandelion Chocolate since 2021 and involved in investments at C1 since 2019. Previously, Clara held multiple roles at Mars from 2010 to 2019, including leadership positions in business development and emerging markets. Clara co-founded SteMing Asia from 2006 to 2009 and worked as a business analyst at IMS Health from 2004 to 2006. Early in the career, Clara gained experience in healthcare policy and biomedical research. Clara holds a Bachelor of Arts in Biochemistry from Harvard University, an MBA from INSEAD, and another MBA from the China Europe International Business School (CEIBS). Educational background also includes training from Thomas Jefferson High School for Science and Technology, Wei Hua Chinese School, and Harvard Business School.